Active	Status	Sponsor type	Region	Phase	Filter
10 Active 1 Inactive 11 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

10 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jacobs, Nic
NCT05758883: Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)	Completed	N/A	196	US		AcuFocus, Inc.	Cataract, Presbyopia	02/24	02/24
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery	Recruiting	N/A	200	US	Corneal Collagen Cross-linking	Glaukos Corporation	Corneal Ectasia	02/26	02/26
Swan, Russell
NCT04549935: The PRIME Study: A Randomized, Controlled, Prospective Study	Recruiting	4	20	US	Dextenza, Topical Prednisolone	Vance Thompson Vision - MT	Patient Preference, Patient Outcomes, Post-Operative Inflammation, Grade of Post-Operative Cystoid Macular Edema, Rate of Post-Operative Cystoid Macular Edema	08/21	08/21
NCT05136924: IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL	Not yet recruiting	2	20	US	OC-01 (varenicline 1.2mg/ml) nasal spray vs Placebo, Placebo (vehicle) nasal spray	Vance Thompson Vision - MT	Dry Eye Disease	06/22	06/22
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery	Recruiting	N/A	200	US	Corneal Collagen Cross-linking	Glaukos Corporation	Corneal Ectasia	02/26	02/26
NCT06060041: IC-8 Apthera IOL New Enrollment Post Approval Study	Recruiting	N/A	435	US		Bausch & Lomb Incorporated	Cataract, Presbyopia, Posterior Capsule Opacification	09/27	09/27
Parker, Briana
NCT04549935: The PRIME Study: A Randomized, Controlled, Prospective Study	Recruiting	4	20	US	Dextenza, Topical Prednisolone	Vance Thompson Vision - MT	Patient Preference, Patient Outcomes, Post-Operative Inflammation, Grade of Post-Operative Cystoid Macular Edema, Rate of Post-Operative Cystoid Macular Edema	08/21	08/21
NCT05136924: IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL	Not yet recruiting	2	20	US	OC-01 (varenicline 1.2mg/ml) nasal spray vs Placebo, Placebo (vehicle) nasal spray	Vance Thompson Vision - MT	Dry Eye Disease	06/22	06/22
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery	Recruiting	N/A	200	US	Corneal Collagen Cross-linking	Glaukos Corporation	Corneal Ectasia	02/26	02/26
NCT06060041: IC-8 Apthera IOL New Enrollment Post Approval Study	Recruiting	N/A	435	US		Bausch & Lomb Incorporated	Cataract, Presbyopia, Posterior Capsule Opacification	09/27	09/27

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jacobs, Nic
NCT05758883: Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)	Completed	N/A	196	US		AcuFocus, Inc.	Cataract, Presbyopia	02/24	02/24
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery	Recruiting	N/A	200	US	Corneal Collagen Cross-linking	Glaukos Corporation	Corneal Ectasia	02/26	02/26
Swan, Russell
NCT04549935: The PRIME Study: A Randomized, Controlled, Prospective Study	Recruiting	4	20	US	Dextenza, Topical Prednisolone	Vance Thompson Vision - MT	Patient Preference, Patient Outcomes, Post-Operative Inflammation, Grade of Post-Operative Cystoid Macular Edema, Rate of Post-Operative Cystoid Macular Edema	08/21	08/21
NCT05136924: IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL	Not yet recruiting	2	20	US	OC-01 (varenicline 1.2mg/ml) nasal spray vs Placebo, Placebo (vehicle) nasal spray	Vance Thompson Vision - MT	Dry Eye Disease	06/22	06/22
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery	Recruiting	N/A	200	US	Corneal Collagen Cross-linking	Glaukos Corporation	Corneal Ectasia	02/26	02/26
NCT06060041: IC-8 Apthera IOL New Enrollment Post Approval Study	Recruiting	N/A	435	US		Bausch & Lomb Incorporated	Cataract, Presbyopia, Posterior Capsule Opacification	09/27	09/27
Parker, Briana
NCT04549935: The PRIME Study: A Randomized, Controlled, Prospective Study	Recruiting	4	20	US	Dextenza, Topical Prednisolone	Vance Thompson Vision - MT	Patient Preference, Patient Outcomes, Post-Operative Inflammation, Grade of Post-Operative Cystoid Macular Edema, Rate of Post-Operative Cystoid Macular Edema	08/21	08/21
NCT05136924: IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL	Not yet recruiting	2	20	US	OC-01 (varenicline 1.2mg/ml) nasal spray vs Placebo, Placebo (vehicle) nasal spray	Vance Thompson Vision - MT	Dry Eye Disease	06/22	06/22
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery	Recruiting	N/A	200	US	Corneal Collagen Cross-linking	Glaukos Corporation	Corneal Ectasia	02/26	02/26
NCT06060041: IC-8 Apthera IOL New Enrollment Post Approval Study	Recruiting	N/A	435	US		Bausch & Lomb Incorporated	Cataract, Presbyopia, Posterior Capsule Opacification	09/27	09/27